Mark Kendall

2012 Laureate, Science & Health
Australia, Born 1972

m.kendall@uq.edu.au

Vaccine breakthrough may herald end of polio

September 7, 2016

A revolutionary method for delivering vaccine protection against infectious disease, especially in developing regions, is achieving spectacular results in lab trials carried out for the World Health Organization (WHO). The ‘nanopatch’, invented by Rolex laureate and medical engineer Mark Kendall, has delivered a 40-fold improvement in...

READ MORE ON THE ROLEX AWARDS BLOG

Polio trial for Nanopatch

February 6, 2015

The World Health Organization is backing clinical trials of Mark Kendall’s Nanopatch using a polio vaccine. A revolutionary vaccine delivery technology, the Nanopatch, may help strike the final blow in the world’s 60-year struggle against one of the most feared childhood diseases – poliomyelitis. In...

READ MORE ON THE ROLEX AWARDS BLOG

Next step for the Nanopatch

November 20, 2013

In 2012, using funds from his Rolex Award, Laureate Mark Kendall tested the usability and thermo-stability of his vaccine patch in a trial (without using vaccine) in Papua New Guinea. This “mock” trial resulted in key lessons on the use of the Nanopatch in the developing world, which have...

READ MORE ON THE ROLEX AWARDS BLOG

Other 2012 Laureates